Remap Consulting presented NICE’s methodology for highly specialized technologies (ultra orphan disease with a prevalence of <1:50,000) to EUCOPE members at their meeting in Brussels on the 20th November.
Articles
Remap Consulting presented NICE’s methodology for highly specialized technologies (ultra orphan disease with a prevalence of <1:50,000) to EUCOPE members at their meeting in Brussels on the 20th November.